Bioplus History

2019 ~

Entry to total health care and well-being industry from focusing on materials for medical treatment

2020

  •   APPROVAL IN CLINICAL TRIAL OF BIO-MATERIAL FOR ARTICULAR RECUPERATION (MARCH 2020)
  •   APPROVAL IN GMP (GOOD MANUFACTURING PRACTICES) & CE FOR THE SEONGNAM 2ND FACTORY
  •   ENTRY TO THE PROJECT IN HAINAN ISLAND OF CHINA AS THE ONLY DOMESTIC COMPANY (APRIL 2020)

2019

  •   GYEONGGIDO SEONGNAM 2ND PLANT AND R&D CENTER EXPANSION / BUSINESS CENTERT GYEONGGIDO SEOGNAM (19.10)
  •   ESTABLISHMENT OF 5 BRANCHES IN OVERSEAS (DUBAI, NEW DELHI)
  •  InterBlock( ANTI ADHESIVE BARRIER AGENT) KFDA COMPLETION (19. 2.) / CE CERTIFICATION (19. 2.)
  •   SYNOVIAL FLUID REPLACEMENT IRB
  •  SYNOVIAL FLUID REPLACEMENT EXPORT LICENSE (19. 3.)
  •   MDSAPCERTIFICATION : FILLER, ANTI-ADHESIVE BARRIER AGENT

2008 ~ 2018

Expansion of R&D intrastructure and construction of cutting-edge manufacturing facilities.

2016 ~ 2018

  •   InterBlock (ANTI ADHESIVE BARRIER AGENT) EXPORT LICENSE (16. 10.)
  •   InterBlock (ANTI ADHESIVE BARRIER AGENT) IRB APPROVED (17. 5.)

2014 ~ 2015

  •   SkinPlus-Hyal® COMPLETED CLINICAL TRIALS (SEOUL NATIONAL UNIVERSITY HOSPITAL – SEOUL, BUNDANG)
  •   SkinPlus-Hyal®, DENE B® CE certification
  •   SkinPlus-Hyal® KGMP(formerly, KFDA)
  •   SkinPlus-Hyal® KFDA Item permission
  •   HyalDew® KFDA Item permission

2013

  •   Completion of Daejeon Plant 1 and R&D Center

2010 ~ 2011

  •   MANUFACTURING AND PRODUCT LICENSE (FOR EXPORT)

2008 ~ 2009

  •   SKINPLUS-HYAL® COMPLETED BIOCOMPATIBILITY AND SAFETY TEST / COMPLETED PRECLINICAL TEST

2003 ~ 2007

Development of products based on polymeric olysaccharide(hyaluronic acid)

2003

  •    ESTABLISHMENT OF BIOPLUS CO., LTD.
  •  PERFORMED VARIETY OF FILLER RESEARCH INCLUDING COLLAGEN AND MICROBEAD FILLER
  •   SELECTION OF HA BASED FILLER AND COMPLETED DEVELOPMENT